EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anti‐thymocyte globulin induction with delayed introduction of tacrolimus preserves renal function in pediatric liver transplant recipients

Michael E Rogers iD, Teresa Ambrosino, Laura Hatcher, Alex Bondoc, Greg Tiao, Anna L Peters iD

Pediatric Transplantation · 2023

DOI: 10.1111/petr.14509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2023. Verfasst von Michael E Rogers und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Tacrolimus, Liver Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NIDDK NIH HHS, National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tacrolimus (TAC)‐mediated renal disease occurs in up to 70% of pediatric liver transplant (LT) recipients. The safety and efficacy of renal‐sparing immunosuppression using anti‐thymocyte globulin (ATG) induction and delayed TAC administration has not been studied in children. We evaluated the safety and efficacy of ATG induction on preserving renal function in children within the first year (Y1) post‐LT in a single‐center retrospective cohort study.

Methods

Children under age 18 years of who received isolated LT from 2008 to 2020 with a GFR < 70 received renal‐sparing (RS) protocol consisting of ATG with methylprednisolone (MP), delayed TAC administration, lower initial TAC trough goals, and mycophenolate mofetil (MMF). The RS group was matched 1:2 by age and LT indication with standard immunosuppression (SI) group. Changes in renal function as well as adverse events within Y1 post‐LT were compared.

Results

Forty‐four pediatric patients were included in the analysis, of which 13 received RS. As expected, the RS group had significantly lower mean TAC trough levels at 30 days (10.3 vs. 13.2, p = .001) post‐LT. Renal function was significantly preserved at 6 (−0.26 vs. 0.21, p = .004) and 12 months (−0.33 vs. 0.11, p = .003) post‐LT in the RS versus SI group as measured by mean change in serum creatinine, with similar trends observed in eGFR and cystatin C. ACR, sepsis, viremia, graft loss and mortality occurred at similar rates in both RS and SI groups.

Conclusion

Induction immunosuppression with ATG and delayed TAC administration in children with renal impairment is safe and effectively preserves renal function during Y1 post‐LT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusLiver TransplantationHumansChildAdolescentAntilymphocyte SerumImmunosuppressive AgentsRetrospective StudiesMycophenolic AcidKidneyGraft RejectionGraft Survival

Stichwörter der Autor:innen

anti-thymocyte globulinantilymphocyte antibodiescomplications of liver transplantationimmunosuppressionpediatric liver transplantationrenal insufficiencytacrolimus toxicity

Substanzen

TacrolimusAntilymphocyte SerumImmunosuppressive AgentsMycophenolic Acid

Autor:innen und Institutionen

  • Department of Pediatric Gastroenterology Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department of Pediatric General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

ORCID-Profile: Michael E Rogers, Anna L Peters

Förderung

  • NICHD NIH HHS
  • NIDDK NIH HHS
  • National Institute of Child Health and Human Development
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Cincinnati Children's Hospital Medical Center

Zitieren

APA

Rogers, M. E., Ambrosino, T., Hatcher, L., Bondoc, A., Tiao, G., & Peters, A. L. (2023). Anti‐thymocyte globulin induction with delayed introduction of tacrolimus preserves renal function in pediatric liver transplant recipients. Pediatric Transplantation. https://doi.org/10.1111/petr.14509

Vancouver

Rogers ME, Ambrosino T, Hatcher L, Bondoc A, Tiao G, Peters AL. Anti‐thymocyte globulin induction with delayed introduction of tacrolimus preserves renal function in pediatric liver transplant recipients. Pediatric Transplantation. 2023. doi:10.1111/petr.14509

BibTeX
@article{Rogers2023,
  author = {Rogers, Michael E and Ambrosino, Teresa and Hatcher, Laura and Bondoc, Alex and Tiao, Greg and Peters, Anna L},
  title = {Anti‐thymocyte globulin induction with delayed introduction of tacrolimus preserves renal function in pediatric liver transplant recipients},
  journal = {Pediatric Transplantation},
  year = {2023},
  doi = {10.1111/petr.14509}
}
Kostenlos starten →